Guides and Documents
The following guidance documents have been created by the Swelife-ATMP project SDP1-regulatory and the ATMP2030 Innovationmilieu.
The absence of detailed guidance for Advanced Therapy Medicinal Product (ATMP) development initiated the development of these guidance documents which we suggest should be used in combination with our public regulatory guide. Please remember that each ATMP is unique.